Jiang Xiao-Zhong, Zhao Shao-Yong, Luo Hong, Huang Bin, Wang Chang-Song, Chen Lei, Tao You-Jiang
Department of General Surgery, No. 2 People's Hospital of Yibin City, Yibin 644000, Sichuan Province, China.
World J Gastroenterol. 2009 Jul 21;15(27):3421-5. doi: 10.3748/wjg.15.3421.
To compare the outcomes of laparoscopic and open splenectomy and azygoportal devascularization for portal hypertension.
From June 2006 to March 2009, laparoscopic splenectomy and azygoportal disconnection (LSD) were performed on 28 patients with cirrhosis, bleeding due to portal hypertension, and secondary hypersplenism. Success was achieved in 26 patients. Demographic, intraoperative, and postoperative variables of the patients were compared.
Success of laparoscopic splenectomy and azygoportal disconnection was achieved in all but two patients (7.14%) who required open splenectomy and azygoportal devascularization (OSD). The operation time was significantly longer in patients undergoing LSD than in those undergoing OSD (235 +/- 36 min vs 178 +/- 47 min, P < 0.05). The estimated intraoperative blood loss was much more in patients receiving OSD than in those receiving LSD (420 +/- 50 mL vs 200 +/- 30 mL, P < 0.01). The proportion of patients undergoing laparoscopic and open splenectomy and azygoportal disconnection who received transfusion of packed red blood cells during or after the operation was 23.08% and 38.46%, respectively (P < 0.05). The time of first oral intake was faster in patients after LSD than in those after OSD (1.5 +/- 0.7 d vs 3.5 +/- 1.6 d, P < 0.05). The hospital stay of patients after LSD was shorter than that of patients after OSD (6.5 +/- 2.3 d vs 11.7 +/- 4.5 d, P < 0.05). The pain requiring medication was less severe in patients after LSD than in those after OSD (7.69% vs 73.08%, P < 0.001). The overall complication rate was lower in patients after LSD than in those after OSD (19.23% vs 42.31%, P < 0.05).
Laparoscopic splenectomy and azygoportal disconnection are the feasible, effective, and safe surgical procedure, and are advantageous over minimally invasive surgery for bleeding portal hypertension and hypersplenism.
比较腹腔镜脾切除术联合贲门周围血管离断术与开腹脾切除术联合贲门周围血管离断术治疗门静脉高压症的疗效。
2006年6月至2009年3月,对28例肝硬化门静脉高压症并脾功能亢进出血患者行腹腔镜脾切除术联合贲门周围血管离断术(LSD),26例手术成功。比较患者的人口统计学资料、术中及术后变量。
除2例(7.14%)患者因需要行开腹脾切除术联合贲门周围血管离断术(OSD)外,其余患者腹腔镜脾切除术联合贲门周围血管离断术均获成功。LSD组患者手术时间显著长于OSD组(235±36分钟对178±47分钟,P<0.05)。OSD组患者术中估计失血量明显多于LSD组(420±50毫升对200±30毫升,P<0.01)。LSD组和OSD组患者术中或术后接受浓缩红细胞输血的比例分别为23.08%和38.46%(P<0.05)。LSD组患者首次进食时间早于OSD组(1.5±0.7天对3.5±1.6天,P<0.05)。LSD组患者住院时间短于OSD组(6.5±2.3天对11.7±4.5天,P<0.05)。LSD组患者术后需要药物止痛的程度轻于OSD组(7.69%对73.08%,P<0.001)。LSD组患者总体并发症发生率低于OSD组(19.23%对42.31%,P<0.05)。
腹腔镜脾切除术联合贲门周围血管离断术是一种可行、有效、安全的手术方法,在治疗门静脉高压症出血和脾功能亢进方面优于开腹手术。